Ganga Pharmaceuticals Ltd — Important, 13-01-2026: Company Update

Ganga Pharmaceuticals has confirmed that its share registrar, KFIN Technologies, processed all share dematerialization requests for the recent quarter. This includes the proper handling and cancellation of physical share certificates converted into electronic format. This routine update ensures efficient and secure management of investor holdings, maintaining accuracy in the company's share registry and facilitating easier trading for shareholders. It's a key compliance step reflecting robust operational processes.